Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry
Clinical Chemistry; DOI: 10.1373/clinchem.2013.216515.
Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease
Aging Cell; DOI: 10.1111/acel.12281.
Identification and Preclinical Pharmacology of the -Secretase Modulator BMS-869780
International Journal of Alzheimer’s Disease; http://dx.doi.org/10.1155/2014/431858
A Synchrotron-based Hydroxyl Radical Footprinting Analysis of Amyloid Fibrils and Pre-fibrillar Intermediates with Residue-specific Resolution
ACS Publications; DOI: 10.1021/bi5010409.
Ultrasonic force microscopy for nanomechanical characterization of early and late-stage amyloid-β peptide aggregation
Scientific Reports; doi:10.1038/srep04004.
In vitro discrimination of the role of LRP1 at the BBB cellular level: Focus on brain capillary endothelial cells and brain pericytes
Brain Research; doi:10.1016/j.brainres.2014.10.047.
β-Amyloid Fibrils in Alzheimer Disease Are Not Inert When Bound to Copper Ions but Can Degrade Hydrogen Peroxide and Generate Reactive Oxygen Species
The Journal of Biological Chemistry; 10.1074/jbc.M113.525212.
Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Neurobiol Aging.; doi: 10.1016/j.neurobiolaging.2014.05.023.
Transgenic Mice Overexpressing Amyloid Precursor Protein Exhibit Early Metabolic Deficits and a Pathologically Low Leptin State Associated with Hypothalamic Dysfunction in Arcuate Neuropeptide Y Neurons
The Journal of Neuroscience; 10.1523/JNEUROSCI.0872-14.2014.
The amyloid-β degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease
Neuroscience Letters; 10.1016/j.neulet.2014.04.041